State Of Wisconsin Investment Board Passage Bio, Inc. Transaction History

State Of Wisconsin Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.63 - $3.46 $136,757 - $290,294	-83,900 Reduced 72.27%	32,200 $76,000
Q1 2022 May 13, 2022	BUY	$2.66 - $6.49 $181,146 - $441,969	68,100 Added 141.88%	116,100 $360,000
Q3 2021 Nov 12, 2021	BUY	$9.73 - $15.52 $39,776 - $63,445	4,088 Added 9.31%	48,000 $478,000
Q2 2021 Aug 12, 2021	BUY	$12.44 - $19.45 $306,173 - $478,703	24,612 Added 127.52%	43,912 $581,000
Q4 2020 Feb 03, 2021	SELL	$14.28 - $29.73 $34,272 - $71,352	-2,400 Reduced 11.06%	19,300 $493,000
Q2 2020 Aug 12, 2020	BUY	$14.59 - $36.07 $316,603 - $782,719	21,700 New	21,700 $593,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $25.6M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.